| Title |
<p>Refractory Sarcoidosis: A Review</p>
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, April 2020
|
| DOI | 10.2147/tcrm.s192922 |
| Pubmed ID | |
| Authors |
Thomas El Jammal, Yvan Jamilloux, Mathieu Gerfaud-Valentin, Dominique Valeyre, Pascal Sève |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 76 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 10 | 13% |
| Student > Bachelor | 10 | 13% |
| Researcher | 6 | 8% |
| Student > Ph. D. Student | 6 | 8% |
| Student > Doctoral Student | 4 | 5% |
| Other | 16 | 21% |
| Unknown | 24 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 34% |
| Nursing and Health Professions | 4 | 5% |
| Neuroscience | 3 | 4% |
| Business, Management and Accounting | 2 | 3% |
| Social Sciences | 2 | 3% |
| Other | 11 | 14% |
| Unknown | 28 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2020.
All research outputs
#13,687,626
of 23,225,652 outputs
Outputs from Therapeutics and Clinical Risk Management
#617
of 1,277 outputs
Outputs of similar age
#185,489
of 370,841 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 19 outputs
Altmetric has tracked 23,225,652 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,277 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,841 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.